CVS Health Corporation
CVS
$63.66
-$3.85-5.70%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 93.55B | 89.49B | 88.65B | 84.94B | 83.52B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 93.55B | 89.49B | 88.65B | 84.94B | 83.52B |
| Cost of Revenue | 79.94B | 76.19B | 75.32B | 71.90B | 69.99B |
| Gross Profit | 13.61B | 13.30B | 13.33B | 13.04B | 13.54B |
| SG&A Expenses | 10.17B | 9.78B | 9.72B | 9.58B | 9.80B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 90.11B | 85.97B | 85.03B | 81.48B | 79.79B |
| Operating Income | 3.44B | 3.52B | 3.61B | 3.46B | 3.74B |
| Income Before Tax | 2.71B | 3.02B | 2.57B | 2.88B | 3.15B |
| Income Tax Expenses | 658.00M | 754.00M | 656.00M | 737.00M | 818.00M |
| Earnings from Continuing Operations | 2.05B | 2.27B | 1.91B | 2.14B | 2.33B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.00M | -4.00M | -13.00M | -6.00M | 2.00M |
| Net Income | 2.05B | 2.26B | 1.90B | 2.14B | 2.33B |
| EBIT | 3.44B | 3.52B | 3.61B | 3.46B | 3.74B |
| EBITDA | 4.57B | 4.65B | 4.72B | 4.46B | 4.78B |
| EPS Basic | 1.59 | 1.76 | 1.48 | 1.66 | 1.78 |
| Normalized Basic EPS | 1.43 | 1.51 | 1.56 | 1.57 | 1.61 |
| EPS Diluted | 1.59 | 1.75 | 1.48 | 1.65 | 1.77 |
| Normalized Diluted EPS | 1.42 | 1.51 | 1.56 | 1.56 | 1.60 |
| Average Basic Shares Outstanding | 1.29B | 1.29B | 1.28B | 1.28B | 1.31B |
| Average Diluted Shares Outstanding | 1.29B | 1.29B | 1.29B | 1.29B | 1.32B |
| Dividend Per Share | 0.61 | 0.61 | 0.61 | 0.61 | 0.55 |
| Payout Ratio | 38.07% | 34.45% | 41.82% | 36.47% | 30.81% |
